These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7297919)

  • 1. Effect of loperamide and naloxone on gastric acid secretion in healthy man.
    Caldara R; Cambielli M; Masci E; Guslandi M; Barbieri C; Ferrari C
    Gut; 1981 Sep; 22(9):720-3. PubMed ID: 7297919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of an opiate agonist and antagonist on the human upper gastrointestinal tract.
    Rees WD; Sharpe GR; Christofides ND; Bloom SR; Turnberg LA
    Eur J Clin Invest; 1983 Jun; 13(3):221-5. PubMed ID: 6191994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of naloxone on met-enkephalin-induced gastric acid secretion and serum gastrin in man.
    Olsen PS; Kirkegaard P; Petersen B; Christiansen J
    Gut; 1982 Jan; 23(1):63-5. PubMed ID: 7056498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an opiate antagonist (naloxone) on the gastric acid secretory response to sham feeding, pentagastrin, and histamine in man.
    Feldman M; Cowley YM
    Dig Dis Sci; 1982 Apr; 27(4):308-10. PubMed ID: 7067583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of endogenous opioids on gastric functions in man].
    Suzuki J
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):836-48. PubMed ID: 8112709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of loperamide, a peripheral opiate agonist, on circulating glucose, free fatty acids, insulin, C-peptide and pituitary hormones in healthy man.
    Caldara R; Testori GP; Ferrari C; Romussi M; Rampini P; Borzio M; Barbieri C
    Eur J Clin Pharmacol; 1981; 21(3):185-8. PubMed ID: 6797827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation by peripheral opioids of basal and distension-stimulated gastric acid secretion in the rat.
    Esplugues JV; Barrachina MD; Esplugues J
    Br J Pharmacol; 1992 May; 106(1):33-8. PubMed ID: 1504729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loperamide-induced inhibition of pancreatic secretion in rats.
    Appia F; Chariot J; Roze C; De La Tour J; Vaille C
    Eur J Pharmacol; 1984 Aug; 103(1-2):71-9. PubMed ID: 6479231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.
    Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
    Hepatogastroenterology; 1990 Feb; 37(1):124-7. PubMed ID: 2107135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.
    Basilisco G; Bozzani A; Camboni G; Recchia M; Quatrini M; Conte D; Penagini R; Bianchi PA
    Gut; 1985 Jul; 26(7):700-3. PubMed ID: 4018633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans.
    Konturek SJ; Kwiecień N; Obtułowicz W; Swierczek J; Bielański W; Oleksy J; Coy DH
    Gut; 1983 Aug; 24(8):740-5. PubMed ID: 6409709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of gastrointestinal motility by loperamide in dogs.
    Fioramonti J; Fargeas MJ; Bueno L
    Dig Dis Sci; 1987 Jun; 32(6):641-6. PubMed ID: 3568951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in basal nocturnal, meal-stimulated, and pentagastrin-stimulated gastric secretion values in a sample of healthy volunteers in basal conditions and under ranitidine influence.
    Carranza-Madrigal J; Herrera-Abaraca JE; Chavez-Carbajal F; Campos-Perez Y; Salazar LA
    Control Clin Trials; 1996 Jun; 17(3):258-65. PubMed ID: 8877261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
    Auernhammer CJ; Riepl RL; Schopohl J; Lehnert P; Müller OA; Stalla GK
    Neuroendocrinology; 1994 Jul; 60(1):16-22. PubMed ID: 8090278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor. Mechanisms to inhibit gastric acid secretion in conscious dogs.
    Lenz HJ; Hester SE; Brown MR
    J Clin Invest; 1985 Mar; 75(3):889-95. PubMed ID: 3872315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociated effects of somatostatin on gastric acid secretion and mucosal blood flow.
    Leung FW; Guth PH
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G337-41. PubMed ID: 2858159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a mast cell stabiliser (FPL 52694) on human gastric secretion.
    Boyd EJ; Wilson JA; Wormsley KG; Richards MH; Langman MJ
    Agents Actions; 1985 Sep; 16(6):462-7. PubMed ID: 4072827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic control of gastric acid and gastrin secretion in man: lack of effects after acute oral administration of ibopamine, an analogue of dopamine.
    Caldara R; Masci E; Barbieri C; Cambielli M; Ferrari C; Tittobello A
    Br J Clin Pharmacol; 1983 Jul; 16(1):112-4. PubMed ID: 6882619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loperamide: studies on its mechanism of action.
    Sandhu BK; Tripp JH; Candy DC; Harries JT
    Gut; 1981 Aug; 22(8):658-62. PubMed ID: 6269968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetorphan, an enkephalinase inhibitor, decreases gastric secretion in cats.
    Bado A; Chicau-Chovet M; Appia F; Dubrasquet M; Lecomte JM; Rozé C
    Peptides; 1987; 8(1):89-93. PubMed ID: 3554169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.